---
document_datetime: 2025-12-16 08:25:45
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/libmeldy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: libmeldy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 7.7935952
conversion_datetime: 2025-12-28 08:36:16.024247
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Libmeldy

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,youmayneedtoalsorefertoEPAR-Proceduralstepstakenandscientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amended on   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|-------------------------------------------|---------------------------------|-----------|
| VariationtypeIA/    | This was an application for a group of | 15/12/2025                          | N/A                                       | Annex II and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000317597                    | variations. B.III.1.bEuropeanPharmacopoeial TSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/or excipient - B.III.1.b.3 Updated certificate from an already approved manufacturer- Accepted A.ADMINISTRATIVECHANGES-A.7 Deletionofmanufacturingsitesforan active substance,intermediate orfinishedproduct, packagingsite,manufacturerresponsiblefor batchrelease,sitewherebatchcontrol takes place,orsupplierof astartingmaterial, reagent or excipient (when mentioned in the dossier)*- Accepted   |            |     | PL   |
|--------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| Variation typeIB / EMA/VR/0000302098 | This was an application for a group of variations. B.1.b.2 Change in test procedure for active substance or starting material/reagent/intermediateusedinthe manufacturingprocessof theactive substance-B.1.b.2.e Other changes to a test procedure (including replacement or addition)fortheactive substance or a starting material/intermediate - Accepted B.I.e.5Implementationofchangesforeseen inanapprovedchangemanagement                                                                                                                 | 05/12/2025 | N/A |      |

<div style=\"page-break-after: always\"></div>

|                                          | protocol - B.I.e.5.c Implementation of a changeforabiological/immunological medicinal product - Accepted                                                                                                                                                                                                                                          |            |            |                                  |                                                                                                                                                                                                                                 |
|------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000309575    | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance-Accepted                                                                                                                                                                                       | 21/11/2025 | N/A        |                                  |                                                                                                                                                                                                                                 |
| Renewal - 5 year/ EMA/R/0000257479       | -Renewal -Accepted                                                                                                                                                                                                                                                                                                                                | 18/09/2025 | 21/11/2025 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy,theCHMPconsideredthatthebenefit-risk balanceofLibmeldyin the approved indication remainsfavourable and thereforerecommended the renewalofthemarketingauthorisation. |
| Variation type IA_IN / EMA/VR/0000288053 | A. ADMINISTRATIVE CHANGES - A.1 Change in the name and/or address of the marketing authorisationholder-Accepted                                                                                                                                                                                                                                   | 25/07/2025 | 21/11/2025 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                 |
| VariationtypeIB/ EMA/VR/0000256254       | B.I.a.1 Change in the manufacturer of a startingmaterial/reagent/intermediateused inthemanufacturingprocessoftheactive substanceorchangeinthemanufacturer (includingwhererelevantqualitycontrol testingsites)oftheactive substance,where noPh.Eur.Certificate of Suitability is part of the approved dossier-B.I.a.1.z Other variation - Accepted | 28/03/2025 | N/A        |                                  |                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| Variation type IB / EMA/VR/0000247071   | B.1.b.2 Change in testprocedure for active substance or starting material/reagent/intermediateused in the manufacturingprocessoftheactive substance-B.1.b.2.e Other changes to a test procedure (including replacement or addition) for the active substance or a starting material/intermediate - Accepted                                                                                                                                                                                                                                                                                                                                                     | 21/02/2025   | N/A   |
|-----------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| Variation type IB / EMA/VR/0000245274   | This was an application for a group of variations. B.1.b.2 Change in test procedurefor active substance or starting material/reagent/intermediateused in the manufacturingprocessoftheactive substance-B.1.b.2.e Other changes to a test procedure (including replacement or addition)fortheactive substance or a startingmaterial/intermediate-Accepted B.1.b.2 Change in testprocedure for active substance or starting material/reagent/intermediateusedinthe manufacturingprocessoftheactive substance-B.1.b.2.e Other changes to a test procedure (including replacement or addition) for the active substance or a startingmaterial/intermediate-Accepted | 17/02/2025   | N/A   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|                          | substance or starting material/reagent/intermediate used in the manufacturing process of the active substance-B.I.b.2.e Other changes to a test procedure (including replacement or addition)fortheactivesubstanceora starting material/intermediate -Accepted   |             |
|--------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
| PSUR/EMA/PSUR/0000257860 |                                                                                                                                                                                                                                                                  | Maintenance |